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ANALYSIS

Communicating about screening
Informed choice is important for screening, but not everyone wants or is able to analyse research
data. Vikki Entwistle and colleagues propose a new approach to communication
People are offered a wide range of screening tests by diverse providers. For example:
maternal and child health services screen
for genetic conditions and developmental problems; general practitioners screen
for cardiovascular risk factors; NHS programmes screen for bowel, breast, and cervical cancer; and commercial providers offer
various health assessments, including body
and gene scans. Provision of tests is not well
regulated, and there is a bewildering amount
of information of variable accuracy in the
public domain.1
It is unclear how healthcare providers
should communicate about screening in
order to support appropriate uptake. And
what constitutes appropriate uptake is also
contested because of disagreements about
the merits of particular tests and tensions
between concerns to promote health and to
respect autonomy.2-4 Debates about communication have tended to consider two types
of approach, which we call “be screened”
and “analyse and choose.” We consider their
problems and propose a third approach,
“consider an offer.”
National screening programmes

Be screened
The be screened approach aims to persuade
people to have screening, usually with a view
to promoting health gain, cost effective service provision, or profit.2-4 Its key features are
encouragement to be screened; an emphasis
on the benefits of screening and de-emphasis of
potential harms; and a lack of recognition that
it might be reasonable not to be screened.
This approach is found in commercial
advertisements and some invitations to participate in government funded screening
programmes. For example, the leaflet Breast
Cancer: the Facts, from the NHS Breast Cancer
Screening Programme presents screening as
necessary for women aged over 50.5 It asks,
“Should all women have breast screening?”
and gives no hint of any scope for a negative answer. The leaflet highlights the benefits
of mammography and describes the main
processes but plays down potential harms. It
does not mention that screening may lead to
overtreatment or that clinicians and epidemiologists seriously dispute the value of breast
screening. It gives no indication that women
might reasonably choose not to be screened,
Clinicians

Commercial screening test providers

Recommendations or offers of screening
consistent with the consider an offer approach
(Ideally) supportive relationships that promote
and sustain autonomy

Other information relating to screening, ideally
including screening literacy campaigns

Do I have enough information to decide whether or not to accept the offer?

Yes:
Offer is not from a source
I trust or I have reason
not to accept it

Yes:
Offer is from a source I
trust, and I have reason
to accept it

No:
I need
additional
information

Further information or
support from other sources
Now what do I think?

Reject offer

Accept offer

Overview of the consider an offer approach
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More detailed
information, including
research data about
benefits and harms
(possibly in a decision
aid) from original
source

and includes a breast awareness code that
instructs women to “Go for breast screening
every 3 years if you are over 50.”
The main criticisms of the be screened
approach are that it inadequately reflects the
benefit-harm profile of screening tests and
fails to respect autonomy because it does
not facilitate informed decision making by
individuals.6-8 Some communications with
features typical of this approach purport to
facilitate informed choice, but they present
only one option: to be screened.
Analyse and choose
The analyse and choose approach is one
response to criticisms of the be screened
approach. It emphasises respect for autonomy and treats this as a matter of ensuring
that competent individuals have sufficient
understanding of their options and can
make intentional, sufficiently independent
choices.9 It assumes that sufficient understanding requires comprehension of detailed
research based information about benefits
and harms and promotes informed individual decision making based on this.
The key features of this approach are an
emphasis on the importance of individual
(sometimes independent) choice and the
provision of comparative data about the
various outcomes of screening and no
screening. The approach is exemplified by
decision aids, which seek to present the data
in accessible ways.
There are three main criticisms of the analyse and choose approach. Firstly, the implication that everyone eligible for screening
should consider detailed effectiveness data
may be unnecessarily burdensome. This
criticism is particularly strong when expert
committees acting in the public interest have
reviewed the available research, judged the
tests to be broadly effective and acceptable,
and supported the introduction of government
endorsed screening programmes. Secondly,
there are concerns that encouraging detailed
decision analysis by individuals might not
lead to good choices (it might disrupt people’s usual effective decision making processes) or deter uptake of effective, appropriate
screening.4 7 10 11 Thirdly, some critics think
this approach overemphasises rational and
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independent decision making—reflecting an
inappropriately narrow understanding of
autonomy.
New considerations
Recent research into decision making has
highlighted some potential downsides of
detailed decision analysis and maximising
(aiming to make the best possible choice). It
suggests that heuristics and “satisficing” (aiming to make good enough choices) can be
less burdensome and yield better decisions
and outcomes.12 13
The understanding of autonomy that prevails in health care has been criticised for
focusing too narrowly on discrete decisions,
over-idealising rationalism, and inappropriately assuming that interpersonal collaboration and trust will compromise rather than
promote autonomy.14-16 Although autonomy
relates to individuals, it is both developed
and exercised in the context of social relationships.16-18 People who use “intellectual
outsourcing” to help shape their opinions,
and who do not process detailed data for
themselves before they choose or act, do
not necessarily fail to exercise autonomy,18

although others who try to impose their
views and discourage competent consideration of alternatives do tend to undermine it.
Neither of the two approaches above considers the importance of the interests and
trustworthiness of those who offer and advise
about screening. This failing, together with
recent evidence about what patients value
about communication with health professionals19 and involvement in decision making,20 leads us to suggest a third approach to
communication about screening.
Consider an offer
The consider an offer approach is designed to
respect personal autonomy without overburdening people with unwanted information and
decision making tasks and without deterring
uptake of effective and personally appropriate
screening. Within this approach, communicators either recommend or offer screening or
help people to consider recommendations or
offers from others. They openly explain and
discuss the basis for the recommendation or
offer; encourage and facilitate an individual
assessment of the recommendation or offer
(including consideration of the potential bias

and trustworthiness of those making it and of
its personal relevance); provide or facilitate
access to further information if that is required;
and acknowledge that the recommendation or
offer might reasonably be refused.
Just what information and how much detail
are required will vary across screening tests,
contexts, and individuals, but will usually
include a summary of the potential benefits
and harms of the test considered, consideration of any known objections to it, information about test providers, and factors that
might affect the appropriateness of the test
for particular individuals (table). The optional
extra information might include detailed data
on outcomes and, more controversially, other
people’s experiences and preferences, especially in value laden contexts such as screening for fetal abnormality.7
When presented with a screening offer,
people might reasonably respond in various
ways. Some might judge the trustworthiness
and personal relevance of a screening offer on
the basis of the initial communication; others
might habitually seek and follow the advice
of a trusted health professional; and others
might want to evaluate research evidence for

Illustration of communication by general practitioner consistent with consider an offer approach to screening
Key communication topics
Who made the recommendation or offer?

What is the basis of the recommendation,
and what are the main benefits and harms of
screening?

Are there any factors that make the screening
test more appropriate for some people than
others?

Who might gain from screening and how are
people protected?

Is more information needed?
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Rationale

Response to a healthy 45 year old’s query
about prostate cancer screening
Being able to depend on others appropriately
Although several men’s groups are
is essential for autonomy.16 Information
campaigning for screening, the National
about the individuals, committees, and
Screening Committee, which is required to
organisations that recommend or offer screening review the evidence very carefully, does not
can help people assess their trustworthiness
think that routine screening for prostate cancer
and identify potential concerns about their
is justified
recommendations or offers
An explanation of how a recommendation
Although prostate cancer kills many men, a lot
was reached may help people to assess
of men have prostate cancer but do not die from
its trustworthiness. Information about
it . . . Prostate specific antigen (PSA) testing
consequences is an important component of
will pick up some prostate cancers but will
practical reasoning, and people usually want to also miss some. And we can’t tell which of the
know (or at least not be misled about) the main
prostate cancers that it does pick up would be
reasons for or against healthcare interventions
life threatening. When a man is found to have
prostate cancer after being screened, no one can
be sure if current treatments will leave him better
off than if he had not been screened. Research is
ongoing, but at the moment we really don’t know
the overall effects of PSA testing
Beyond a clear statement about who a
Prostate cancer is rare in men under 50 and
recommendation or offer applies to, it may be
you have no family history of prostate cancer,
useful to highlight circumstances that can make so the chances of you having it are relatively
screening more or less appropriate for particular low. But if you are particularly anxious about it
individuals—eg, age and risk exposures that
and concerned to find out, then we should take
modify the likelihood of benefit and values that that into account—but still bearing in mind that
can give people reason to accept or decline
the test is not 100% accurate and may lead to
screening tests
unnecessary treatment
Information about the financial and other
Although I wouldn’t really recommend it, I can
significant interests of the organisations and
arrange for a PSA test for you on the NHS…
individuals that recommend, offer, and provide You’ll find private health care providers more
screening are relevant in some contexts
enthusiastic about the test—but then they can
make money from it in a way that I can’t
People’s information needs vary. Initial
communications can usefully encourage
people to consider whether they have enough
information and enable those who want more to
access other potentially useful sources

Has that given you enough information, or
would you like more detail or more time to think
about it? I have a leaflet here that summarises
the information we’ve talked about, and it lists
a few other sources of information

Recommendation of cardiovascular risk
assessment
The National Institute for Health and Clinical
Excellence and all the major professional
and patient groups have worked together
and now recommend that we carry out a
cardiovascular risk assessment for most
people aged 45 and over
Studies following thousands of people over
several decades have allowed experts to
develop accurate estimates of how likely
individuals are to have a heart attack or
stroke, based on their age, sex, family
history, blood pressure, blood cholesterol,
and whether they smoke. Many things can
be done to reduce the risk and screening
would allow us to discuss options
appropriate for your level of risk

You’re a heavy smoker, which increases
your risk of heart disease and stroke. If
you’re worried about having a stroke like
your uncle, screening might help us think
again about the smoking and look at other
ways you can reduce that risk

The income we get from government to
help run the practice depends in part on
us doing some of these checks, but we
recommend it because we think it can help
patients. The practice would still care for
you if you chose not to be screened
Does that give you enough to go on? I
can give you more information, or point
you towards a website that explains the
assessment in more detail
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Patients offered screening can be helped to consider whether a test is appropriate

themselves—at least for some tests. It should be
feasible to respond to these varied preferences
even when communications are necessarily
standardised to some extent. For example,
mailed invitations from national screening programmes can encourage people to consider
whether they would like more information and
tell them where to find additional resources
and personal support.
This approach respects autonomy because
it encourages and enables people to consider
screening offers carefully. Although it can
incorporate strong recommendations, it does
not close down opportunities for thoughtful
refusals of screening. For example, practitioners will avoid presenting screening as routine16
or necessary and will ensure people feel they
can safely say they do not think a test is right
for them. The consider an offer approach can
facilitate informed decision making about
screening, providing summary information
about the benefits and harms of screening to all
and decision aids with more detailed epidemiological information to those who want them
(figure), but it does not assume that autonomous choice or informed decision making
will always require every individual to work
through detailed statistics for themselves.
Because it accepts the reality of intellectual
outsourcing18 and the importance of trust,
the consider an offer approach makes people
vulnerable to manipulation: trust can be both
inappropriately placed and abused.21 However, this vulnerability is arguably no greater
than with the be screened approach. Consider
an offer provides some protection by discussing the basis of recommendations or offers,
facilitating assessment of the trustworthiness of
those who make them, and raising questions

about the adequacy of the information supplied. The further protection that the analyse
and choose approach offers by encouraging
rational personal decisions based on detailed
data on outcomes is not practical for many.
For screening programmes backed by agencies such as the National Screening Committee, the consider an offer approach should not
adversely affect uptake of broadly effective
tests. Communication consistent with this
approach should help people to recognise
when providers are trustworthy. In contrast,
the be screened approach might lead to mistrust over time if people come to realise practitioners have underplayed the downsides of
screening.
The consider an offer approach is less
demanding on those eligible for screening
than the analyse and choose approach, but it
puts more onus on providers to communicate
in a range of ways to meet diverse information needs. Some programmes already use
features of consider an offer—for example,
information about newborn bloodspot tests
presents recommendations and explanations
and points out that tests are not compulsory.22
But if the approach is found to be successful,
health service agencies will need to develop
more resources to support adoption by front
line health professionals.
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